Home Antitrust Chronicle

Antitrust Chronicle - Last Issue

Antitrust Chronicle Killer Acquisitions MAY 2020-2

Killer Acquisitions

What is a killer acquisition? The term was first employed in the pharmaceutical sector to describe acquisitions by an incumbent of a competitor that threatened to launch a blockbuster drug that would undermine its own products, with a view to shutting it down. In recent times, the term has broadened to cover other industries, notably the tech sector, where companies allegedly acquire startups to acquire their technology, either to quell a nascent threat, or to integrate it to their own offerings, further entrenching their dominance.

In this Issue

In Case You Missed It

May 2020 - I

April 2020 - II

April 2020 - I

Chronicles by Year

Most Read Articles